Novavax, Inc. (NVAX)
NASDAQ: NVAX ยท Real-Time Price ยท USD
7.62
-0.10 (-1.30%)
Nov 20, 2026, 2:07 PM EST - Market open
Novavax Financials Overview
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 411.65 | 1,123 | 682.16 | 983.71 | 1,982 | 1,146 |
Revenue Growth | -61.33% | 64.69% | -30.65% | -50.37% | 72.89% | 141.02% |
Gross Profit Gross Profit Growth | 21.81 | 713.62 | 91.65 | -94.77 | -89.48 | -1,388 |
Operating Income Operating Income Growth | -69.88 | 563.24 | -231.93 | -552.21 | -644.74 | -1,687 |
Net Income Net Income Growth | -76.73 | 440.3 | -187.5 | -545.06 | -657.94 | -1,744 |
Earnings Per Share EPS Growth | -0.47 | 2.58 | -1.23 | -5.41 | -8.42 | -23.44 |
EPS Growth | - | - | - | - | - | - |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
United States United States Growth | 282.7 | 405.61 | 522.54 | 443.89 |
Europe Europe Growth | 26.65 | 15.74 | 96.14 | 271.96 |
Rest of The World Rest of The World Growth | 102.3 | 126.46 | 59.02 | 254.46 |
Rest of North America Rest of North America Growth | - | 575.67 | 4.46 | 13.39 |
Total Total Growth | 411.65 | 1,123 | 682.16 | 983.71 |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 622.36 | 735.08 | 923.12 | 568.51 | 1,337 | 1,515 |
Total Debt Total Debt Growth | 295.26 | 278.05 | 263.47 | 280.64 | 616.73 | 524.09 |
Net Cash (Debt) Net Cash Growth | 327.1 | 457.04 | 659.65 | 287.87 | 720.15 | 991.03 |
Net Cash Growth | -36.08% | -30.71% | 129.15% | -60.03% | -27.33% | 332.45% |
Net Cash Per Share Net Cash Per Share Growth | 2.00 | 2.64 | 4.33 | 2.86 | 9.21 | 13.32 |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | -238.95 | -244.64 | -87.26 | -713.97 | -415.94 | 322.95 |
Capital Expenditures CapEx Growth | -4.3 | -5.56 | -13.06 | -53.77 | -89.06 | -54.5 |
Free Cash Flow Free Cash Flow Growth | -243.25 | -250.2 | -100.32 | -767.74 | -504.99 | 268.45 |
Free Cash Flow Growth | - | - | - | - | - | - |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 5.30% | 63.52% | 13.44% | -9.63% | -4.52% | -121.10% |
Operating Margin | -16.98% | 50.13% | -34.00% | -56.14% | -32.53% | -147.13% |
Pretax Margin | -17.47% | 39.36% | -25.89% | -55.20% | -32.98% | -149.57% |
Profit Margin | -18.64% | 39.19% | -27.49% | -55.41% | -33.20% | -152.12% |
FCF Margin | -59.09% | -22.27% | -14.71% | -78.05% | -25.48% | 23.42% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 20, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | 2.48 | - | - | - | - |
Forward PE | 100.26 | 8.33 | 28.96 | 3.15 | 3.15 | 10.46 |
P/FCF Ratio | - | - | - | - | - | 40.30 |
PS Ratio | 3.08 | 0.97 | 1.89 | 0.58 | 0.45 | 9.44 |